Iordanis Arzimanouglou has thirty-year postdoctoral international career. Since June 2020, he has been Programme Manager for Health and Biotechnology at the EIC, where he´s responsible for developing visions for technological and innovation breakthroughs. Iordanis has previously worked as EIC Coach & Senior advisor to genomic/genetic SMEs. Iordanis was the Chief Executive Officer at the Aarhus Biotech Clyster Company (BMF) and was Associate Professor at the Department of Biomedicine Aarhus University. Earlier in his career, he was Assistant Professor of Molecular Genetics at Weill Medical College of Cornell University, New York and prior to that, he was Chief of Cancer Genetics Research Program at Lennox Hill Hospital, New York. Before joining Lenox Hill, he was a research scientist in the Division of Medical Genetics at Weill Medical College of Cornell University. Iordanis holds a PhD from the University of Athens, Greece in Molecular Genetics and Biochemistry, a Boston University Graduate Certificate in international business management and performed his postdoctoral work in the Department of Medicine at Weill Medical College of Cornell University, New York.